Garry E. Menzel
Chief Operating Officer, Regulus Therapeutics Inc.
Companies
- Adaptimmune (United Kingdom)Board member Jun 1, 2023 to now1
- Stoke Therapeutics, Inc.Board member Jan 27, 2021 to now2
- Black Diamond Therapeutics, Inc.Board member Jan 29, 2020 to now3
- TCR2 THERAPEUTICS INC.Board member Feb 13, 2019 to Jun 1, 20234
- TCR2 THERAPEUTICS INC.Chief executive officer Feb 13, 2019 to Jun 1, 20234
- TCR2 THERAPEUTICS INC.President Feb 13, 2019 to Jun 1, 20234
- DaVitaSenior Vice President, Finance Sep 11, 2013 to Sep 11, 20135
- Regulus Therapeutics Inc.Chief operating officer Oct 4, 2012 to Dec 13, 20126
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARTCR2 THERAPEUTICS INC., Board member
- 5
- 6